Newcastle Clinical Trials Unit

Staff Profile

Dr Rachel Lakey

Trial Manager


Trial Manager on the following studies:

  • Efficacy of Acipimox in patients with Mitochondrial Myopathy Trial (AIMM)
  • Prehabilitation in Elective Patients undergoing Cardiac Surgery: A Randomised Controlled Trial (PrEPS)
  • Minimally invasive thoracoscopically-guided right minithoracotomy versus conventional sternotomy for mitral valve repair: a multicentre randomised controlled trial (UK Mini Mitral)
  • Stroke: an evaluation of Thrombectomy in the Ageing Brain - where IV thromboLysis IS contraindicated (STABILISE)


PhD Matrix Biology 2008 (Northumbria University)


Member of the UK Trial Managers' Network 


Previous Positions

Clinical Trials Officer (March 2009 - Aug 2014, North East Stroke Research Network)

Research Technician (Sept 2001 - Dec 2008, Newcastle University, Musculoskeletal Research Group) 

Junior Laboratory Technician (Sept 1997 - Aug 2001, Newcastle Upon Tyne Church High School)


I've had experience of working in all areas of translational research, from lab based, hospital ward & clinic based, to trial management, I am able fully understand all aspects of translational medicine from benchside to bedside and I am able to use this to great effect in all areas of trial management.



Research Background

I began my research career in 2001 as a Research Technician in the Musculoskeletal Research Group, based in the Newcastle University Medical School. I worked on research looking at the degradation of cartilage. In 2008 I completed my Phd, looking at Matrix metalloproteinases (MMPs) and the prevention cartilage matrix degradation.

In 2009, I moved to work in the NHS as a Clinical Trials Officer for the North East Stroke Research Network, where I worked on the setup and recruitment for large a range of trials from Hyper-acute to long term prevention and rehab.

In September 2014, I left the NHS to return to Newcastle University as Trial Manager in the Newcastle Clinical Trials Unit, where currently manager trials for Stroke, Bronchiectasis and Mitochondrial disease.